Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2005
11/17/2005DE102004010828B3 Verfahren und Mittel zum thermischen Konditionieren einer Zelle Method and means for thermal conditioning a cell
11/17/2005CA2566189A1 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production
11/17/2005CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005CA2560264A1 Gm1 promoter and use thereof
11/16/2005EP1595955A1 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/16/2005EP1595949A1 Method of degrading plastic and process for producing useful substance using the same
11/16/2005EP1595942A1 Process for encapsulating or immobilisation of microorganisms
11/16/2005EP1594967A1 MICROBIAL PRODUCTION OF C sb O /sb Q10
11/16/2005EP1594953A1 Yeast compositions and starter cultures
11/16/2005EP1594881A1 Concurrent microorganism identification and susceptibilities from broth
11/16/2005EP1594560A2 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
11/16/2005EP1594369A1 Control of enzymatic degradation of glucosinolates by lactic acid bacterium
11/16/2005EP1434853B1 Fermentation with cyclic pulse-pause feeding
11/16/2005EP1399568B1 Method for producing recombinant trypsin
11/16/2005EP1144318B1 Method for treating an effluent using simultaneous nitrification/denitrification in a trickling filter
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP1082423B1 Cyclin e2 genes and proteins
11/16/2005EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
11/16/2005EP0939799B1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase
11/16/2005EP0871746B1 Carboxypeptidases from aspergillus oryzae and nucleic acids encoding same
11/16/2005EP0871703B1 Dna encoding glutamate gated chloride channels
11/16/2005EP0788547B1 Purified coprinus laccases and nucleic acids encoding same
11/16/2005EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof
11/16/2005EP0477295B2 Platelet aggregation inhibitors
11/16/2005CN1696301A Process for clavulanic acid production by microbial thallus
11/16/2005CN1696282A Culture medium of anaerobic toxin production in use for producing vaccine of treating disease of sheep clostridium
11/16/2005CN1696281A New microbe gene stock similar to lactobacillus casei GM-O80, and application for treating disease related to irritability
11/16/2005CN1696280A Technique for planting north aweto in rice bag in high efficiency
11/16/2005CN1696279A Method for preparing epsi-polylysine and its salt by using Kitasatosporia PL6-3
11/16/2005CN1696277A Method for culturing microbe in use for improving internal environment of animal
11/16/2005CN1696276A Twol steps continuous fermentation technology for beneficial microbe (EM) to improve water quality
11/16/2005CN1227367C Diagnostic system and method for determining presence of genotoxic compound in sample
11/16/2005CN1227363C Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/16/2005CN1227362C Biosynthetic genes for spinosyn insecticide production
11/16/2005CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
11/16/2005CN1227355C Acetate proof mutant escherichia coli DH5 alpha and its culturing method and use
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227353C Method for artificial culture of cordyceps, e.g. Cordyceps mititaris
11/16/2005CN1227352C Method for producing protein feed by fermenting the waste water from saponin production
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227166C Method for denitrogenation of water
11/16/2005CN1226936C Carbohydrate-based enzyme granulates
11/15/2005US6965021 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964957 For use in therapy of neurodegenerative diseases and certain cancers
11/15/2005US6964951 Polynucleotide
11/15/2005US6964868 Human polynucleotides; genetic engineering
11/15/2005US6964865 Host cells comprising Streptomyces clavuligerus chromosomal DNA fragments encoding enzymes for β-lactam antibiotic biosynthesis
11/15/2005US6964864 Using yeast cells; culturing in presence of alternating current
11/15/2005US6964863 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
11/15/2005US6964855 Peptides for detection to Anaplasma phagocytophilum
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964847 Derivative nucleic acids and uses thereof
11/15/2005US6964845 Thermostable phage lambda operator mutants for regulating gene expression
11/15/2005US6964771 Storage stability; foamed glass containign active material ; boiling, foaming
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964760 Lantibiotics for treatment and prevention of bacterial infections; useful in antimicrobial or antiseptic dentifrice
11/15/2005CA2230049C Solvent extraction of polyhydroxyalkanoates from biomass facilitated by the use of a marginal nonsolvent for pha
11/15/2005CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/15/2005CA2162481C Marker gene
11/15/2005CA2150526C Biotechnological process for the preparation of cyclic s-.alpha.-amino carboxylic acids and r-.alpha.-amino carboxamides
11/10/2005WO2005106895A1 Method of removing radioactive substance with microbe and removing composition
11/10/2005WO2005106040A2 Method and device for sample preparation control
11/10/2005WO2005106011A2 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005WO2005106005A1 Process for producing hydroxycarboxylic acid
11/10/2005WO2005105999A1 Improved method for the production of vitamin b12
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105991A1 Amp deaminase originating in streptomyces and utilization thereof
11/10/2005WO2005105980A1 Probiotic composition
11/10/2005WO2005105979A1 Bacterial consortium nbc2000 and method for biologically treating endocrine disrupters using the nbc2000
11/10/2005WO2005105978A2 Drying process for preserving an active agent as a highly viscous liquid
11/10/2005WO2005104649A2 Autolytic yeasts (bgs4 delta), production method thereof and applications of same in protein expression methods
11/10/2005WO2005087914A3 Method for making a liquid concentrate of food-grade acclimated and viable bacteria
11/10/2005US20050251881 Carotenoid ketolase gene
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050250937 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
11/10/2005US20050250841 Autoinducer molecule
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250207 Retrons for gene targeting
11/10/2005US20050250199 Multicompartment, miniaturized fluidic apparatus analytical for use in propagation of DNA sequences; gene expression analysis
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250192 Bacillus which produce lactic acid
11/10/2005US20050250190 Crypthecodinium cohnii biomass cultured to synthesize docosahexaenoic acid
11/10/2005US20050250187 Microorganisms and processes for producing L-glutamine
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250181 Cell-wall degrading enzyme variants
11/10/2005US20050250179 Inhibition of sulfate-reducing-bacteria-mediated degradation using bacteria which secrete antimicrobials
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050250144 Novel genes encoding protein kinase/protein phosphatase
11/10/2005US20050249840 Active yeast in dry granular or powder form obtained through treatment of a mixture of known yeasts and its use in a pre-packed long-life preparation to be completed with the addition of water
11/10/2005US20050249755 Mutant strains of Brucella melitensis and immunogenic compositions
11/10/2005US20050249753 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv (KCTC 1010BP)
11/10/2005US20050249752 Vector for anti-hpv vaccine and transformed microorganism by the vector
11/10/2005US20050249748 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249741 Novel Semaphorin gene: Semaphorin W
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods